Shineyo Medical, a Shanghai-based manufacturer of electrophysiological and peripheral interventional devices, has reportedly secured nearly RMB 100 million (USD 13.9 million) in a Series A+ financing round. The funding was spearheaded by Guangzhou Jinkong Fund, with additional investments from Zhuopu Investment fund, Jinxin Capital, and Zhangjiagang Industrial Capital, along with ongoing support from existing investor Industrial Securities Capital. The capital raised will be allocated towards building a commercial team, operating production facilities, and fueling research and development for the company’s product pipeline.
Established in May 2020, Shineyo Medical has been developing innovative products for cardiac electrophysiology and peripheral vascular intervention. The company’s portfolio includes a pulse electric field ablation system (PFA) and vein closure system, both of which are awaiting regulatory approval in China.- Flcube.com
